scholarly journals The Relationship between Murottal Therapy and Pain Quality in College Students with Musculoskeletal Pain in 2019

2020 ◽  
Vol 1 (2) ◽  
pp. 7
Author(s):  
Thyra Annisaa Putri ◽  
Aulia Chairani ◽  
Riezky Valentina
Keyword(s):  
College Students ◽  
Musculoskeletal Pain ◽  
Rating Scale ◽  
Numeric Rating Scale ◽  
Medical Faculty ◽  
Learning Activities ◽  
Nordic Musculoskeletal Questionnaire ◽  
The Relationship ◽  
Numeric Rating

ABSTRACT Musculoskeletal pain is often called as musculoskeletal disorder (MSDs). One of the most common causes of musculoskeletal pain is occupational-related causes. Musculoskeletal pain is often experienced by college students. The factors that influence the occurrence of musculoskeletal pain in college students are learning activities as well as static body positions/posture while studying. This causes discomfort in learning activities for college students. This study aims to determine the relationship/correlation between the administration of murottal therapy and the quality of musculoskeletal pain in 2016 class Medical Faculty students of UPN (FK UPN). This research type is semi-experimental using a cohort study design. The sampling technique uses purposive sampling. The research sample used was 68 people. The data was collected at the Medical Faculty of UPN ‘Veteran’ Jakarta using a research instrument in the form of a Nordic Musculoskeletal Questionnaire (NMQ) and measured by the Numeric Rating Scale (NRS) pain scale. The results indicated that 30 students (44.1%) had mild pain, 37 (55.4%) had moderate pain, 1 (1.5%) had severe pain respectively before murottal therapy is given. The results of bivariate analysis using the Wilcoxon test indicated that there was a relationship between murottal therapy and the quality of musculoskeletal pain in 2016 class Medical Faculty students of UPN (p = 0.000). The easy and inexpensive therapy of pain management is necessary such as through the administration of murottal therapy for 15 minutes. Keywords: Musculoskeletal Disorders, Pain, Murottal Therapy   ABSTRAK Nyeri muskuloskeletal sering disebut gangguan muskuloskeletal.Salah satu penyebab terseringnya nyeri muskuloskeletal adalah karena pekerjaan. Nyeri muskuloskeletal seringkali dialami oleh mahasiswa. Faktor-faktor yang berpengaruh pada kejadian nyeri muskuloskeletal pada mahasiswa  adalah kegiatan belajar mengajar serta posisi tubuh statis saat belajar. Hal ini menyebabkan ketidaknyamanan dalam kegiatan belajar mengajar pada mahasiswa.Penelitian ini bertujuan untuk mengetahui hubungan antara pemberian terapi murottal dengan kualitas nyeri muskuloskeletal pada mahasiswa FK UPN angkatan 2016.Jenis penelitian ini semi-eksperimetal dengan desain penelitian kohort.Teknik pengambilan sampel menggunakan purposive sampling. Sampel penelitian yang digunakan sebanyak 68 orang. Pengambilan data dilakukan di Fakultas Kedokteran UPN ‘Veteran’ Jakarta menggunakan instrumen penelitian berupa kuesioner Nordic Musculoskeletal Questionnaire (NMQ) dandiukur dengan skala nyeri Numeric Rating Scale (NRS). Hasil penelitian menunjukkan mahasiswa dengan nyeri ringan sebanyak 30 orang (44,1%), 37 orang nyeri sedang (55,4), 1 orang mengalami nyeri berat (1,5%) sebelum diberikan terapi murottal. Hasil analisis bivariat dengan uji Wilcoxon menunjukkan terdapat hubungan antara terapi murottal dengan kualitas nyeri muskuloskeletal pada mahasiswa FK UPN angkatan 2016 (p=0,000). Manajemen penanganan nyeri dengan terapi yang mudah dan murah diperlukan seperti pemberian terapi murottal selama 15 menit. Kata Kunci: Gangguan Muskuloskeletal, Nyeri, Terapi Murottal

Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial

2019 ◽  
Vol 37 (2) ◽  
pp. 135-143 ◽  
Author(s):  
Jingru Jiang ◽  
Yi Li ◽  
Qingyu Shen ◽  
Xiaoming Rong ◽  
Xiaolong Huang ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Adverse Event ◽  
Neuropathic Pain ◽  
Rating Scale ◽  
Short Form ◽  
Controlled Trial ◽  
Numeric Rating Scale ◽  
Mood States ◽  
Numeric Rating

Purpose Neuropathic pain is an unavoidable treatment-related adverse event among patients with head and neck cancer who are undergoing radiotherapy. We aimed to test the efficacy and safety of pregabalin versus placebo in the treatment of radiotherapy-related neuropathic pain. Patients and Methods This randomized, double-blind, placebo-controlled trial was conducted in four centers in China. Eligible patients with a mean pain intensity score of 4 or more on an 11-point numeric rating scale were randomly assigned to receive either active treatment with a flexible dose of pregabalin or placebo for 16 weeks. The primary efficacy outcome was pain reduction measured on the numeric rating scale. Result There were 128 patients who received treatment as randomly assigned. Pain intensity reduction was 2.44 in the pregabalin arm and 1.58 in the placebo arm at week 16, yielding an adjusted mean difference of 0.87 (95% CI, 0.30 to 1.44; P = .003). In the pregabalin arm, 38 patients (59.4%) achieved at least 30% pain relief versus 21 (32.8%) in the placebo arm ( P = .006). Nineteen patients (29.7%) in the pregabalin group and five (7.8%) in the placebo group achieved 50% or greater pain relief ( P = .003). Total scores on the Profile of Mood States-Short Form, pain severity and functional interference of Brief Pain Inventory-Short Form, as well as the physiology and psychology domain of the WHO Quality of Life-BREF all were reduced significantly at week 16 in patients who received pregabalin compared with those who received placebo. There was no significant difference ( P = .29) in the incidence of experiencing at least one adverse event in the pregabalin arm (n = 35; 54.7%) versus the placebo arm (n = 29; 45.3%). Conclusion Patients treated with pregabalin with radiotherapy-related neuropathic pain had greater pain alleviation, better mood states, and higher quality of life compared with patients in the placebo group, with a good tolerability.

scholarly journals Extended Duration Regional Analgesia for Total Knee Arthroplasty: A Randomised Controlled Trial Comparing Five Days to Three Days of Continuous Adductor Canal Ropivacaine Infusion

2018 ◽  
Vol 46 (3) ◽  
pp. 326-331 ◽  
Author(s):  
S. C. Sargant ◽  
M. J. Lennon ◽  
R. J. Khan ◽  
D. Fick ◽  
H. Robertson ◽  
...  
Keyword(s):  
Total Knee Arthroplasty ◽  
Rating Scale ◽  
Intervention Group ◽  
Numeric Rating Scale ◽  
Secondary Outcome ◽  
Quality Of Recovery ◽  
Adductor Canal ◽  
Total Knee ◽  
Numeric Rating

There is a growing body of evidence in favour of continuous adductor canal block (CACB) for total knee arthroplasty. However, there are no studies describing the optimal duration of the infusion. At our institution the usual practice was to stop the infusion on day three. Our hypothesis was that extending the infusion to five days would improve analgesia and quality of recovery. A prospective, non-blinded, randomised trial was undertaken. Patients received a continuous infusion of 0.2% ropivacaine via an adductor canal catheter for either three or five days. Primary outcome was pain while walking during the 24-hour period up to day five (numeric rating scale from 0 to 10). The minimum clinically important difference was set at 1.5 on the numeric rating scale. Secondary outcome measures included quality of recovery, mobility, pain while walking on postoperative day six, Oxford Knee Scores, and complications. Eighty-six patients were recruited with 43 randomised to each group. Seventy-eight were analysed. Median pain scores reported on day five were significantly better in the intervention group (1 versus 3, P=0.003). Furthermore, quality of recovery (QOR-15) scores were significantly better in the intervention group (133.6 versus 123.4, P=0.017). No statistically significant difference between groups was identified for other secondary outcome measures. CACB prolonged to five days provides superior analgesia and a higher quality of recovery on postoperative days four and five compared to a three-day infusion. This benefit did not extend beyond the period of infusion.

W1173 A Single-Item Numeric Rating Scale Shows Excellent Correlation with Measures of Crohn's Disease Activity and Health-Related Quality of Life

2009 ◽  
Vol 136 (5) ◽  
pp. A-670
Author(s):  
Gil Y. Melmed ◽  
Andrew Ippoliti ◽  
Eric A. Vasiliauskas ◽  
Dermot P. McGovern ◽  
Marla Dubinsky ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Rating Scale ◽  
Numeric Rating Scale ◽  
Health Related Quality ◽  
Excellent Correlation ◽  
Single Item ◽  
Related Quality ◽  
Health Related ◽  
Numeric Rating

scholarly journals Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial

BMJ Open ◽  
2019 ◽  
Vol 9 (11) ◽  
pp. e029449 ◽  
Author(s):  
Berzenn Urbi ◽  
Simon Broadley ◽  
Richard Bedlack ◽  
Ethan Russo ◽  
Arman Sabet
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Disease Progression ◽  
Rating Scale ◽  
Numeric Rating Scale ◽  
Motor Neurone ◽  
Double Blind ◽  
Based Medicine ◽  
Numeric Rating ◽  
Lateral Sclerosis

IntroductionAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder with no known cure and with an average life expectancy of 3–5 years post diagnosis. The use of complementary medicine such as medicinal cannabis in search for a potential treatment or cure is common in ALS. Preclinical studies have demonstrated the efficacy of cannabinoids in extending the survival and slowing of disease progression in animal models with ALS. There are anecdotal reports of cannabis slowing disease progression in persons with ALS (pALS) and that cannabis alleviated the symptoms of spasticity and pain. However, a clinical trial in pALS with these objectives has not been conducted.Methods and analysisThe Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease trial is a randomised, double-blind, placebo-controlled cannabis trial in pALS conducted at the Gold Coast University Hospital, Australia. The investigational product will be a cannabis-based medicine extract (CBME) supplied by CannTrust Inc., Canada, with a high-cannabidiol-low-tetrahydrocannabinol concentration. A total of 30 pALS with probable or definite ALS diagnosis based on the El Escorial criteria, with a symptom duration of <2 years, age between 25 and 75years and with at least 70% forced vital capacity (FVC) will be treated for 6 months. The primary objective of the study is to evaluate the efficacy of CBME compared with placebo in slowing the disease progression measured by differences in mean ALS Functional Rating Scale-Revised and FVC score between the groups at the end of treatment. The secondary objectives are to evaluate the safety and tolerability of CBME by summarising adverse events, the effects of CBME on spasticity, pain, weight loss and quality of life assessed by the differences in mean Numeric Rating Scale for spasticity and Numeric Rating Scale for pain, percentage of total weight loss and ALS specific quality of life-Revised questionnaire.Ethics and disseminationThe study has been approved by the local Institutional Review Board. The results of this study will be published in a peer-reviewed journal.Trial registration numberNCT03690791

scholarly journals Long-Term Outcome After Operative Management of Talus Fractures

2018 ◽  
Vol 39 (12) ◽  
pp. 1432-1443 ◽  
Author(s):  
Wouter Vints ◽  
Giovanni Matricali ◽  
Eric Geusens ◽  
Stefaan Nijs ◽  
Harm Hoekstra
Keyword(s):  
Rating Scale ◽  
Short Form ◽  
Operative Management ◽  
Numeric Rating Scale ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Foot Function ◽  
Numeric Rating

Background: Controversies remain regarding the preferred treatment strategy for talus fractures. The primary goal of this study was to evaluate the long-term outcome after operative management of talus fractures. Secondarily, we identified those factors that affected the outcome and defined strategies to improve the outcome. Methods: This is a retrospective outcome study of 84 patients with an average follow-up time of 9.1 years. We assessed the functional results, return to daily activities, and general health status using the Foot Function Index-5pt, a numeric rating scale for pain, and the Short Form-36 Health Survey. Furthermore, we conducted a correlation analysis between the outcomes and 14 demographic, clinical, and radiologic variables. Results: We found moderate mean Foot Function Index pain and disability scores of 30.2 and 28.7, respectively. The mean numeric rating scale score was 3.2. Of all responders, 41% (27/66) did not return to their daily activities. We reported low physical, but good mental, Short Form-36 component summary scores of 42.7 and 48.3, respectively. We recorded a complication rate of 56%. Osteoarthritis, articular incongruence and talus body fractures correlated significantly with a poorer functional outcome. Delayed surgery after trauma was associated with better outcome measures. Conclusions: Talus fractures have a major long-term impact on ankle and hindfoot function and on physical health. Success of operative treatment depends on the occurrence of osteoarthritis postoperatively, type of fracture, and quality of fracture reduction. Because only the latter is modifiable, efforts should be made to restore articular congruence in order to improve the outcome. Therefore, we recommend reviewing the quality of the reduction postoperatively on CT. Furthermore, talus fractures should not be considered operative emergencies, but rather treated after recovery of the soft-tissues. Level of Evidence: Level III, comparative study.

scholarly journals The Effects of Treatment of Korean Medicine for Superior Labrum Anterior to Posterior Lesions: A Retrospective Chart Review

2020 ◽  
Vol 37 (1) ◽  
pp. 49-58
Author(s):  
Ju-Hun Park ◽  
Hyun-Woo Cho ◽  
Han-Bin Park ◽  
Dong-Hwi Yoo ◽  
Sang-Gyun Kim ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Rating Scale ◽  
Numeric Rating Scale ◽  
Slap Lesion ◽  
Korean Medicine ◽  
Slap Lesions ◽  
Lesion Type ◽  
The Mean ◽  
Numeric Rating

Background: This study aimed to investigate the clinical effectiveness of treatment of Korean medicine on superior labrum anterior to posterior (SLAP) lesions.Methods: A total of 55 inpatients diagnosed with SLAP lesions by magnetic resonance imaging, were investigated from May 1<sup>st</sup>, 2014 to May 31<sup>st</sup>, 2019 at Haeundae Jaseng Hospital of Korean Medicine. The patients were sorted by gender, age, causing factor, illness duration, period of hospitalization, SLAP lesion type, complications, and treatments. Treatments included acupuncture, pharmacopuncture, Chuna therapy, herbal treatment, and physiotherapy. After treatment, the Numeric Rating Scale, Shoulder Pain and Disability Index, and European Quality of Life 5-Dimension questionnaire were used to evaluate treatment effect.Results: There were more males than females in this study (1:0.83). Patients were more likely to be in their 50s (38.18%), have an unknown etiology (70.91%), and be in the subacute disease stage (41.82%). According to the SLAP lesion type, most of the inpatients had Type 2 lesions (69.09%). For inpatients diagnosed with SLAP lesions, the mean shoulder numeric rating scale score decreased from 5.55 ± 0.90, to 4.07 ± 1.18 (p < 0.001), the mean Shoulder Pain and Disability Index score decreased from 50.35 ± 18.36, to 39.90 ± 19.34 (p < 0.001), and the mean European quality of life 5-dimension index increased from 0.70 ± 0.16, to 0.75 ± 0.13 (p < 0.01) after treatment.Conclusion: Treatment of Korean medicine effectively decreased pain and increased the quality of life of the patients with SLAP lesions in this study.

Sign in / Sign up

Export Citation Format

Share Document